Introduction: Various metabolic pathways clearly indicate how importantly thyroid and kidney are interrelated; any alteration of thyroid gland leads to change of thyroid hormone levels and modifies the renal function and any disorder in renal function can retard the normal pathway of thyroid hormone. So, the present study is planned to estimate the level of serum electrolytes in hyperthyroid patients.

Material and Methods: The study was undertaken in subjects of age group 20-65 years. Subjects were taken from outpatient department of medicine in Government Medical College, Jammu. Detailed explanation of the purpose and methodology of the tests was given to all subjects and all eligible subjects were requested to participate in the study. Subjects were divided into two groups.

Group A Euthyroid and Group B Hyperthyroid.

Conclusion: The present study shows that there is no significant difference in mean serum sodium and serum potassium between euthyroid and hyperthyroid subjects as this study was planned to show abnormalities of renal function in thyroid dysfunction.

Keywords: Serum electrolytes, hyperthyroidism.

1. Katz AI, Emmanouel DS and Lindheimer MD. Thyroid hormone and the kidney.Nephron 1975; 15: 223-249.
2. Capasso G, DeTommaso G, Pica A, Anastasio P, Capasso J, Kinne R and De Santo NG.Effects of thyroid hormones on heart and kidney functions. Mineral and Electrolyte Metabolism 1999; 25: 56–60.
3. Henry JB. Evaluation of liver function. Clinical Diagnosis and Management by Lab Methods,12^th edition 2003; 275-76.
4. Kaptein EM. Thyroid function in renal failure. Contributions to Nephrology 1986; 50:64–72.
5. Braunlich H. Thyroid hormones influencing renal electrolyte excretion in saline loaded rats of different ages. Physiologia Bohemoslovaca 1984; 33:303–308.
6. Kaptein EM, Feinstein EI and Massry SG.  Thyroid hormone metabolism in renal diseases  Contributions to Nephrology 1982; 33: 122–135.
7. Brohee D, Delespesse G, Debisschop MJ and Bonnyns M. Circulating immune complexes in various thyroid diseases. Clinical and Experimental Immunology 1979; 36: 379–383.
8. Vargas F, Moreno JM, RodríguezGómez I,Wangensteen R, Osuna A, Alvarez-Guerra M and García-Estañ J. Vascular and renal function in experimental thyroid disorders. European Journal of Endocrinology 2006; 154:197–212.
9. Kaptein EM, Quion-Verde H, Chooljian CJ, Tang WW, Friedman PE, Rodriquez HJ and Massry SG. The thyroid in end-stage renal disease. Medicine1988; 67: 187-197
10. Patel YC, Alford FP and Burger HG.The 24 hour plasma thyrotropinprofile. Clin Sci 1972; 43: 71-77.
11. Sterling K and Lazarus JH.The thyroid and its control. Annu Rev Physiol 1977; 39: 349-71.
12. Den Hollander JG, Wulkan RW, Mantel MJ and Berghout A. Correlation between severity of thyroid dysfunction and renal function. Clinical Endocrinology 2005; 62(4): 423- 7.
13. Venditti P and Di MeoS. Thyroid hormone induced oxidative stress. Cell Mol Life and treatment  of  non‐Hodgkin's  lymphoma  of  the  thyroid g land. Ann Surg Oncol 2001; 8: 338–41.
14. Dooner HP, Prada J, Aliaga C and Hoyl C. The Liver in Thyrotoxicosis. Arch Intern Med 1967; 120(1): 25-32.

Dr Meenakshi Sharma